SIRT1 and cancer: This cascade of events underscores metformin’s capacity to harness the SIRT1/NF-κB signaling axis to drive pyroptosis and positions metformin as a novel therapeutic option to induce pyroptotic cell death in cancer cells, particularly those resistant to traditional apoptotic pathways [46].